Left Renal Vein Division for Juxtarenal Aortic Exposure
1 other identifier
observational
110
1 country
1
Brief Summary
Retrospective study on the outcome of the renal function in patients operated because of juxtarenal aortic aneurysms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2020
CompletedFirst Submitted
Initial submission to the registry
September 19, 2021
CompletedFirst Posted
Study publicly available on registry
September 23, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2021
CompletedSeptember 23, 2021
September 1, 2021
1.2 years
September 19, 2021
September 19, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Renal function after surgery.
The level of creatinine in the blood was measured after surgery at several time points.
24 months
Study Arms (4)
A
Group of patients in whom the left renal vein was divided for exposure of the aorta.
A+
Subgroup of group A in whom a communicating vein to the left ascending lumbar vein was present.
A-
Subgroup of group A in whom a communicating vein to the left ascending lumbar vein was not present.
B
Group of patients in whom the left renal vein was mobilized but not divided for exposure of the aorta.
Interventions
Surgical procedure in which an aortic aneurysm is excluded.
Eligibility Criteria
Patients who were treated surgically for a juxtrarenal aortic aneurysm with an open operation.
You may qualify if:
- Only patients who went for a planned operation because of a juxtarenal aortic aneurysm were included in this retrospective analysis.
You may not qualify if:
- Emergency surgery Rupture Pending rupture
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Vascular Surgery, Medical University of Vienna
Vienna, Austria
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Andreas Selberherr, PhD, FEBS
Study Record Dates
First Submitted
September 19, 2021
First Posted
September 23, 2021
Study Start
October 1, 2020
Primary Completion
December 30, 2021
Study Completion
December 30, 2021
Last Updated
September 23, 2021
Record last verified: 2021-09